GSK3B and Parkinson disease: Specific PD-related pathological challenges by dephosphorylation/inactivation of Akt and dephosphorylation/activation of its downstream substrate, GSK-3β may be associated with MPP+- or 6-OHDA-induced neurotoxicity [10,28].